{"id":"tenofovir-gel","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Vaginal irritation"},{"rate":"5-10%","effect":"Vaginal discharge"},{"rate":"5-10%","effect":"Vaginal itching"}]},"_chembl":{"chemblId":"CHEMBL483","moleculeType":"Small molecule","molecularWeight":"287.22"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Tenofovir gel is a microbicide that contains the antiretroviral drug tenofovir, which is a nucleotide reverse transcriptase inhibitor (NtRTI). It is designed to be applied topically to the vagina to prevent HIV transmission. When applied, tenofovir is absorbed into the vaginal mucosa, where it inhibits the activity of reverse transcriptase, an enzyme that HIV uses to replicate its genetic material.","oneSentence":"Tenofovir gel works by inhibiting the replication of HIV by blocking the action of reverse transcriptase.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:38:00.120Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of HIV transmission in women"}]},"trialDetails":[{"nctId":"NCT04066881","phase":"PHASE2","title":"A Combination Efficacy Study in Africa of Two DNA-MVA-Env Protein or DNA-Env Protein HIV-1 Vaccine Regimens With PrEP","status":"COMPLETED","sponsor":"MRC/UVRI and LSHTM Uganda Research Unit","startDate":"2020-12-15","conditions":"HIV Infections","enrollment":1512},{"nctId":"NCT01448616","phase":"PHASE4","title":"Effect of Tenofovir on Genital Herpes Simplex Virus (HSV) Shedding","status":"COMPLETED","sponsor":"University of Washington","startDate":"2012-02","conditions":"Herpes Simplex Type II","enrollment":73},{"nctId":"NCT00729573","phase":"","title":"Bone Mineral Density Substudy - An Ancillary Study to MTN-003","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-11","conditions":"HIV Infections","enrollment":518},{"nctId":"NCT00594373","phase":"PHASE1","title":"Interventional Study of Mucosal and Antimicrobial Responses to Repeated Vaginal Applications of Tenofovir Gel in HIV Uninfected Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":30},{"nctId":"NCT00051831","phase":"NA","title":"Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2003-10","conditions":"HIV Infections","enrollment":19},{"nctId":"NCT00028132","phase":"PHASE1","title":"Safety and Acceptability of the Anti-Microbe Vaginal Gel, PMPA Gel","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":120},{"nctId":"NCT01490671","phase":"PHASE2","title":"Evaluating the Safety of Tenofovir Vaginal Gel in HIV-Uninfected Pregnant Women","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00111943","phase":"PHASE2","title":"Safety and Acceptability of a Vaginal Microbicide","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Hepatitis B, Chronic","enrollment":200},{"nctId":"NCT00705679","phase":"PHASE2","title":"Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2009-08","conditions":"HIV Infections","enrollment":5029},{"nctId":"NCT00540605","phase":"PHASE1","title":"Blood Levels of Tenofovir Gel in HIV Uninfected Pregnant Women Planning Cesarean Delivery","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":21},{"nctId":"NCT01136759","phase":"PHASE1","title":"Tenofovir Gel in Pregnancy and Lactation","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2011-03","conditions":"HIV Infections","enrollment":232},{"nctId":"NCT00592124","phase":"PHASE2","title":"Adherence and Acceptability to and Blood Levels of Tenofovir Gel and Tablets in HIV Uninfected Women","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2008-06","conditions":"HIV Infections","enrollment":168},{"nctId":"NCT01687205","phase":"PHASE1","title":"Coital Pharmacokinetics/Pharmacodynamics (PK/PD) of Tenofovir Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-11","conditions":"Pharmacokinetics of 1% Tenofovir Gel Following Coitus, Pharmacodynamics of 1% Tenofovir Gel Following Coitus","enrollment":31},{"nctId":"NCT01232803","phase":"PHASE1","title":"Rectal Safety and Acceptability Study of Tenofovir 1% Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2010-10","conditions":"Rectal Microbicides","enrollment":65},{"nctId":"NCT01768962","phase":"PHASE1","title":"Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2014-04","conditions":"HIV Prevention","enrollment":14},{"nctId":"NCT01687218","phase":"PHASE2","title":"Safety and Acceptability Study of Oral Emtricitabine/Tenofovir Disoproxil Fumarate Tablet and Rectally-Applied Tenofovir Reduced-Glycerin 1% Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-09-25","conditions":"HIV","enrollment":195},{"nctId":"NCT01691768","phase":"PHASE2, PHASE3","title":"Implementation Effectiveness and Safety of Tenofovir Gel Provision Through Family Planning Services","status":"COMPLETED","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2012-10","conditions":"HIV","enrollment":372},{"nctId":"NCT02401230","phase":"PHASE4","title":"PrEP, Lube, and the Rectal Mucosa in MSM at Risk of HIV","status":"COMPLETED","sponsor":"Emory University","startDate":"2015-03","conditions":"HIV","enrollment":86},{"nctId":"NCT01387022","phase":"NA","title":"Trial to Assess the Impact of PrEP to Tenofovir Gel on the Efficacy of Tenofovir-containing ART on Viral Suppression","status":"COMPLETED","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2011-06","conditions":"Antiretroviral Treatment Outcomes","enrollment":59},{"nctId":"NCT01989663","phase":"PHASE1","title":"A Phase I Trial to Assess the Safety of Tenofovir Gel and Film Formulations: FAME 04","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-11","conditions":"HIV","enrollment":78},{"nctId":"NCT00441298","phase":"PHASE2","title":"Safety and Effectiveness Study of a Candidate Vaginal Microbicide for Prevention of HIV","status":"COMPLETED","sponsor":"Centre for the AIDS Programme of Research in South Africa","startDate":"2007-05","conditions":"HIV Infections","enrollment":889},{"nctId":"NCT02280109","phase":"EARLY_PHASE1","title":"Comparison of Tenofovir Vaginal Gel and Film Formulations","status":"COMPLETED","sponsor":"CONRAD","startDate":"2014-11","conditions":"Healthy, HIV","enrollment":10},{"nctId":"NCT00984971","phase":"PHASE1","title":"Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet","status":"COMPLETED","sponsor":"CONRAD","startDate":"2009-09","conditions":"HIV Prevention, HIV Infections","enrollment":18},{"nctId":"NCT01283360","phase":"PHASE1","title":"Microbicide Safety and Acceptability in Young Men","status":"COMPLETED","sponsor":"CONRAD","startDate":"2010-10","conditions":"High Risk MSM, HIV Negative, 18-30 Years of Age","enrollment":249},{"nctId":"NCT01813162","phase":"PHASE1","title":"In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-12","conditions":"HIV Prevention","enrollment":101},{"nctId":"NCT02245945","phase":"PHASE1","title":"Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females","status":"WITHDRAWN","sponsor":"CONRAD","startDate":"","conditions":"HIV Prevention","enrollment":""},{"nctId":"NCT01386294","phase":"PHASE3","title":"Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection","status":"COMPLETED","sponsor":"CONRAD","startDate":"2011-10","conditions":"HIV Prevention","enrollment":2059},{"nctId":"NCT01810315","phase":"PHASE1","title":"Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity","status":"COMPLETED","sponsor":"CONRAD","startDate":"2013-09","conditions":"HIV Prevention","enrollment":40},{"nctId":"NCT02179138","phase":"PHASE1, PHASE2","title":"Paper Applicator Acceptability Study","status":"WITHDRAWN","sponsor":"CONRAD","startDate":"","conditions":"HIV Prevention","enrollment":""},{"nctId":"NCT01421368","phase":"PHASE1","title":"Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-03","conditions":"HIV Prevention","enrollment":72},{"nctId":"NCT01575418","phase":"PHASE1","title":"An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations","status":"COMPLETED","sponsor":"Ian McGowan","startDate":"2013-03","conditions":"HIV Prevention","enrollment":9},{"nctId":"NCT01369303","phase":"PHASE1","title":"Pharmacokinetic and Pharmacodynamic Study of Tenofovir 1% Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2012-01","conditions":"Prevention","enrollment":194},{"nctId":"NCT01575405","phase":"PHASE1","title":"A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally","status":"COMPLETED","sponsor":"Ian McGowan","startDate":"2013-03","conditions":"HIV Prevention","enrollment":13},{"nctId":"NCT00414518","phase":"NA","title":"Safety and Effectiveness of Short-Term Anti-HIV Drug Therapy for Recent HIV-1 Infection","status":"COMPLETED","sponsor":"University of Colorado, Denver","startDate":"2007-01","conditions":"HIV Infections","enrollment":16},{"nctId":"NCT00262522","phase":"PHASE3","title":"Study of Lopinavir/Ritonavir Tablets Versus Soft Gel Capsules and Once Daily Versus Twice Daily Administration, When Coadministered With Nucleoside Reverse Transcriptase Inhibitors in Antiretroviral Naive Human Immunodeficiency Virus Type 1 Infected Subjects","status":"COMPLETED","sponsor":"Abbott","startDate":"2005-11","conditions":"Human Immunodeficiency Virus Infections","enrollment":664},{"nctId":"NCT00561496","phase":"PHASE1","title":"Pharmacokinetic Study of the Vaginal Microbicide Agent 1% Tenofovir Gel","status":"COMPLETED","sponsor":"CONRAD","startDate":"2007-03","conditions":"HIV Infections","enrollment":49}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABORTION SPONTANEOUS"},{"count":1,"reaction":"GASTRIC ULCER"}],"_approvalHistory":[],"publicationCount":124,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["TFV","9-(2-[Phosphonomethoxy]propyl)adenine","Tenofovir disoproxil","9-[2-(Phosphonomethoxy)propyl]adenine","9-[(R)-2-(phosphonomethoxy)propyl] adenine or PMPA"],"phase":"phase_3","status":"active","brandName":"Tenofovir gel","genericName":"Tenofovir gel","companyName":"National Institute of Allergy and Infectious Diseases (NIAID)","companyId":"national-institute-of-allergy-and-infectious-diseases-niaid","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Tenofovir gel works by inhibiting the replication of HIV by blocking the action of reverse transcriptase. Used for Prevention of HIV transmission in women.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}